Annual EBITDA
Summary
- Current Value
- As of today, COR annual EBITDA is $4.98B, up +20.06% on
- Historical Performance
- COR annual EBITDA is up +44.50% over the past 3 years, up +105.46% over the past 5 years
- All-Time High Comparison
- COR annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR annual EBITDA is +45.80% above its 3-year low of $3.42B reached on
- Sector Comparison
- COR annual EBITDA is higher than 97.95% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.98B | +20.1% | +44.5% | +105.5% | +319.7% | |
| Quarterly EBITDA | $1.19B | +10.9% | +47.4% | +64.9% | +289.0% | |
| TTM EBITDA | $4.82B | +16.2% | +43.3% | +85.0% | +299.1% | |
| Price | $367.64 | +46.7% | +131.8% | +263.2% | +883.3% | |
| PE Ratio | 44.22 | +24.0% | +129.6% | – | +168.5% | |
| Annual Revenue | $321.33B | +9.3% | +34.7% | +69.2% | +312.2% | |
| Annual EPS | $7.96 | +5.7% | -1.0% | +147.8% | +258.6% | |
| $3.93B | +29.4% | +43.0% | +94.3% | +261.4% | ||
| Annual Net Income | $1.57B | +3.2% | -5.9% | +146.1% | +146.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.98B | at high | |
| 5Y | $4.98B | at high | |
| All | $4.98B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.42B | +45.8% | |
| 5Y | $2.43B | N/A | +105.5% |
| All | $92.60M | +5283.0% |
EBITDA History
FAQ
What is the current annual EBITDA of COR?
As of today, COR annual EBITDA is $4.98B
What is 1-year change in COR annual EBITDA?
COR annual EBITDA is up +20.06% year-over-year
What is 3-year change in COR annual EBITDA?
COR annual EBITDA is up +44.50% over the past 3 years
How far is COR annual EBITDA from its all-time high?
COR annual EBITDA is currently at its all-time high
How does COR annual EBITDA rank versus sector peers?
COR annual EBITDA is higher than 97.95% of companies in Healthcare sector
When is COR next annual earnings release?
As of today, the next annual earnings release for COR has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, COR quarterly EBITDA is $1.19B, up +6.49% on
- Historical Performance
- COR quarterly EBITDA is up +10.91% year-over-year, up +47.41% over the past 3 years
- All-Time High Comparison
- COR quarterly EBITDA is currently -7.00% below its historical high of $1.28B set on
- 3-Year Low Comparison
- COR quarterly EBITDA is +50.57% above its 3-year low of $789.04M reached on
- Sector Comparison
- COR quarterly EBITDA is higher than 97.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.19B | +6.5% | +10.9% | +47.4% | +64.9% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| TTM EBITDA | $4.82B | +2.5% | +16.2% | +43.3% | +85.0% | |
| Price | $367.64 | -0.2% | +46.7% | +131.8% | +263.2% | |
| PE Ratio | 44.22 | -4.6% | +24.0% | +129.6% | – | |
| Quarterly Revenue | $85.93B | +2.6% | +5.5% | +36.7% | +63.6% | |
| Quarterly EPS | $2.87 | +263.5% | +14.5% | +23.2% | +58.1% | |
| $926.67M | +8.4% | +17.0% | +46.4% | +50.0% | ||
| Quarterly Net Income | $566.13M | +270.0% | +14.7% | +18.9% | +49.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.28B | -7.0% | |
| 3Y | $1.28B | -7.0% | |
| 5Y | $1.28B | -7.0% | |
| All | $1.28B | -7.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.07B | N/A | +10.9% |
| 3Y | $789.04M | +50.6% | |
| 5Y | $720.36M | N/A | +64.9% |
| All | $22.60M | +5156.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of COR?
As of today, COR quarterly EBITDA is $1.19B
What is COR quarterly EBITDA most recent change?
COR quarterly EBITDA was up +6.49% on December 31, 2025
What is 1-year change in COR quarterly EBITDA?
COR quarterly EBITDA is up +10.91% year-over-year
How far is COR quarterly EBITDA from its all-time high?
COR quarterly EBITDA is currently -7.00% below its historical high of $1.28B set on March 31, 2025
How does COR quarterly EBITDA rank versus sector peers?
COR quarterly EBITDA is higher than 97.90% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on
TTM EBITDA
Summary
- Current Value
- As of today, COR TTM EBITDA is $4.82B, up +2.48% on
- Historical Performance
- COR TTM EBITDA is up +16.17% year-over-year, up +43.31% over the past 3 years
- All-Time High Comparison
- COR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR TTM EBITDA is +45.84% above its 3-year low of $3.31B reached on
- Sector Comparison
- COR TTM EBITDA is higher than 97.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.82B | +2.5% | +16.2% | +43.3% | +85.0% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| Quarterly EBITDA | $1.19B | +6.5% | +10.9% | +47.4% | +64.9% | |
| Price | $367.64 | -0.2% | +46.7% | +131.8% | +263.2% | |
| PE Ratio | 44.22 | -4.6% | +24.0% | +129.6% | – | |
| TTM Revenue | $325.78B | +1.4% | +7.5% | +34.7% | +67.5% | |
| TTM EPS | $8.31 | +4.5% | +18.3% | +1.0% | +152.3% | |
| $3.78B | +3.7% | +24.6% | +41.5% | +71.2% | ||
| TTM Net Income | $1.64B | +4.6% | +16.3% | -3.1% | +151.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.82B | at high | |
| 3Y | $4.82B | at high | |
| 5Y | $4.82B | at high | |
| All | $4.82B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.15B | N/A | +16.2% |
| 3Y | $3.31B | +45.8% | |
| 5Y | $2.61B | N/A | +85.0% |
| All | $24.40M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of COR?
As of today, COR TTM EBITDA is $4.82B
What is COR TTM EBITDA most recent change?
COR TTM EBITDA was up +2.48% on December 31, 2025
What is 1-year change in COR TTM EBITDA?
COR TTM EBITDA is up +16.17% year-over-year
How far is COR TTM EBITDA from its all-time high?
COR TTM EBITDA is currently at its all-time high
How does COR TTM EBITDA rank versus sector peers?
COR TTM EBITDA is higher than 97.71% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on
EBITDA Formula
Data Sources & References
- COR Official Website www.cencora.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1140859/000114085926000006/0001140859-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000131/0001140859-25-000131-index.htm
- COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
- COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor
